Therefore, whether the combination of CYFRA 21 − 1 with Ki67 for evaluating the prognosis in advanced NSCLC patients with wild-type EGFR is reliable or not is unclear. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.